Zining Jin
First Hospital of China Medical University(CN)China Medical University(CN)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Cancer Cells and Metastasis, Cancer-related molecular mechanisms research, HER2/EGFR in Cancer Research
Most-Cited Works
- → A novel HIF-2α targeted inhibitor suppresses hypoxia-induced breast cancer stemness via SOD2-mtROS-PDI/GPR78-UPRER axis(2022)90 cited
- → A PAK5–DNPEP–USP4 axis dictates breast cancer growth and metastasis(2019)39 cited
- → Genetic polymorphisms ofmTORand cancer risk: a systematic review and updated meta-analysis(2016)35 cited
- → <p>MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer</p>(2020)34 cited
- → TUFT1 is expressed in breast cancer and involved in cancer cell proliferation and survival(2017)28 cited
- → Expression and clinicopathological significance of FSIP1 in breast cancer(2015)24 cited
- → Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy(2015)24 cited
- → Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple‐Negative Breast Cancer(2020)22 cited
- → Clinical practice guideline for diagnosis and treatment of hyperplasia of the mammary glands: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021(2021)19 cited
- → <p>The Expression and Prognostic Significance of Claudin-8 and Androgen Receptor in Breast Cancer</p>(2020)18 cited